Replacement of Lys27 by asparagine in the SERCA regulator myoregulin: A Ca 2+ affinity modulator or a catalytic activity switch?

Autor: Rathod N; Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada., Guerrero-Serna G; Center for Arrhythmia Research, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI 48109, USA., Young HS; Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada., Espinoza-Fonseca LM; Center for Arrhythmia Research, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: lmef@umich.edu.
Jazyk: angličtina
Zdroj: Biochimica et biophysica acta. Molecular cell research [Biochim Biophys Acta Mol Cell Res] 2024 Jan; Vol. 1871 (1), pp. 119613. Date of Electronic Publication: 2023 Nov 02.
DOI: 10.1016/j.bbamcr.2023.119613
Abstrakt: Myoregulin (MLN) is a protein that regulates the activity of the sarcoplasmic reticulum Ca 2+ -ATPase (SERCA) without affecting its affinity for Ca 2+ . MLN's residue Lys27 is located at a site where other SERCA regulators control Ca 2+ affinity. Therefore, we conducted atomistic simulations and ATPase activity experiments to determine whether replacing Lys27 with asparagine, a conserved residue found in various muscle SERCA regulators, would enable MLN to modulate both the Ca 2+ affinity and catalytic activity of SERCA. Our findings indicate that replacing Lys27 with Asn significantly enhances the inhibitory potency of MLN, but it does not affect SERCA's affinity for Ca 2+ . We suggest that the SERCA site modulating Ca 2+ affinity also acts as a catalytic activity switch. Therefore, this site is a key element contributing to the functional divergence among homologous SERCA regulators. This study paves the way for future investigations to explore how biological function diverges during the evolution of the SERCA regulator family.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: